Review Signalling in Viral Entry

Total Page:16

File Type:pdf, Size:1020Kb

Review Signalling in Viral Entry CMLS, Cell. Mol. Life Sci. 59 (2002) 608–626 1420-682X/02/040608-19 $ 1.50 + 0.20/0 © Birkhäuser Verlag, Basel, 2002 CMLS Cellular and Molecular Life Sciences Review Signalling in viral entry U.F. Greber University of Zürich, Institute of Zoology, Winterthurerstrasse 190, 8057 Zürich (Switzerland), Fax: +41 1 635 6822, e-mail: [email protected] Received 13 September 2001; received after revision 23 October 2001; accepted 16 November 2001 Abstract. Viral infections are serious battles between tracellular signals triggering specific cellular reactions. pathogens and hosts. They can result in cell death, elimi- Responses by cells include stimulation of innate and nation of the virus or latent infection keeping both cells adaptive immunity, growth, proliferation, survival and and pathogens alive. The outcome of an infection is often apoptosis. In addition, virus-activated cell signalling determined by cell signalling. Viruses deliver genomes boosts viral entry and gene delivery, as recently shown for and proteins with signalling potential into target cells and adenoviruses and adeno-associated viruses. This review thereby alter the metabolism of the host. Virus interac- illustrates that multiple activation of host cells during vi- tions with cell surface receptors can elicit two types of ral entry profoundly impacts the elaborate relationship signals, conformational changes of viral particles, and in- between hosts and viral pathogens. Key words. Entry; receptor; signal transduction; trafficking; virus infection. Introduction vaccination programmes have led to the prevention of some virus-caused diseases such as poliomyelitis, he- Viruses are tiny and are largely dependent on their hosts patitis B, virus-associated chronic liver disease and can- for survival. They propagate by replicating inside their cer of the liver [5]. On the other hand, the simplicity of host’s cells. Viruses carry a minimal amount of informa- viruses has made them useful instruments for the study tion with them. A thin protein coat wraps around a small of genetics, cell and structural biology, immunology and bag of genes. Unlike cellular genomes, which are pro- biochemistry [6]. Studies of viruses have also made ma- tected and regulated by a variety of different polypep- jor contributions to our understanding of principal cell tides, viral genomes encode only a few coat and regula- functions, including the structure of DNA, genomic reg- tory proteins [1]. Viruses use their proteins repetitively to ulation, transcription, processing and transport of RNA, build up regular geometrical ‘capsids’ [2], demonstrating protein trafficking and evolution [3, 7]. Viral research that they have evolved effective use of their genetic and has even contradicted a long-standing dogma of molecu- structural outfit [3]. lar biology through the discovery that RNA-containing Despite their apparent simplicity, viruses attract serious retroviruses reverse the normal flow of genetic informa- concern for the misery and illness they cause [4]. Most tion by using an enzyme, reverse transcriptase, to tran- people regard viruses as uninvited and opportunistic scribe single-stranded RNA into double-stranded DNA guests which struggle with their host in an effort to repli- [8, 9]. In contrast to the standard view, viruses might cate and spread their genetic material. Virally transmit- even provide essential functions for the host. One hy- ted diseases range from the common cold to numerous pothesis proposes that endogenous retroviruses (ERVs) forms of immunodeficiencies and cancer. Large-scale of mammals locally suppress a cellular immune response CMLS, Cell. Mol. Life Sci. Vol. 59, 2002 Review Article 609 against the growing placental tissue, thus supporting ac- ceptance of the allogeneic embryo in the mother [10]. A recent report goes further to suggest that a cellular gene captured by a human ERV serves an important function in the generation of trophoblast tissue by stimulating cell-cell fusion [11]. Another attractive speculation is that viruslike transposons are at the evolutionary origin of immunoglobulin heavy chain and the T-cell-receptor b-chain assembly in immature B and T cells, respectively [12]. But how does it happen that viruses utilize their targets so effectively, given that host benefits from viral infections seem to be scarce? The short answer to this question is that viruses are extremely well adapted to their hosts. A major part of this adaptation is that viruses manipulate host cell signalling. Biochemical and genomic analyses in the last decades have revealed that viruses harbor both genetic and nongenetic information with signalling po- tential [3, 13]. At least three principal mechanisms ac- count for viral activation of cells (fig. 1). The delivery of signalling genes is probably the best-studied mechanism, whereas deposition of signalling proteins by incoming vi- ral particles and activation of surface receptors are re- ceiving increasing attention. This review aims to illustrate how viruses utilize signalling, with particular emphasis on how the process of cell entry by viruses can depend on signalling. A detailed review of viral structures and other aspects of viral life cycles is available elsewhere (for re- view, see e.g., [14–18]). Delivery of signalling genes and proteins The advent of high-resolution electron microscopy and reproducible cell-culture technology about 50 years ago enabled the tracking of intracellular viruses and viral genomes during infections. Sequencing of viral genomes Figure 1. Three modes of viral activations of host cells. The most and inventory of viral proteins have revealed that the prevailing activation mode occurs by viral gene expressions (panel genomes of certain retroviruses, for example, contain A). Incoming viruses deliver their genes to subcellular replication sites (steps 1 and 2) and from there drive the transcription of viral cellular genes of crucial signalling function that can lead genes encoding intracellular (steps 3a and 4a) and extracellular sig- to cell transformation and oncogenesis (fig. 1A). In fact, nalling factors (steps 3b and 4b). Panel B: The second mode of sig- the first oncogene discovered was the cellular nonrecep- nalling is a delivery of proteins or mRNAs by incoming viruses tor tyrosine kinase Src, pirated by the chicken Rous sar- (step 1). These molecules can interfere with cell signalling (steps 2 and 3). Panel C: During entry, many incoming viruses recruit a pri- coma virus [19]. Many other cell-derived oncogenes mary receptor (step 1) and/or a secondary receptor with signalling have since been identified in transforming retroviruses. functions (step 2) and thus lead to cell activation (step 3). The corresponding cell-owned protooncogenes are typi- cally involved in mitogenic signalling and include pep- tide growth factors, growth factor receptors, protein and lipid kinases, G proteins and transcription factors (re- tivity (reviewed in [24]). For example, the multifunc- viewed in [20–23]). Viral genomes also contain genes to tional cytokine tumor necrosis factor (TNF-a) is pro- counteract host defence mechanisms. They are necessary duced in activated monocytes and macrophages and ac- for viral survival in an infected organism, since acute in- tivates caspases that lead to apoptosis of infected cells. fections are invariably countered by an innate immune Viral countermeasures include the downregulation of response, mounting type I and type II interferons (IFNs), immune modulating proteins, inhibition of apoptosis, cytokines and increased levels of natural killer cell ac- dysregulation of cytokine production and even destruc- 610 U.F. Greber Signalling in viral entry tion of immune cells (for reviews, see [25, 26]). Aden- Receptors for viral attachment oviruses, for example, counteract the lytic action of TNF-a by a variety of proteins encoded in the E3 region Much work has been devoted to the identification of viral [27]. Poxviruses produce a number of soluble cytokine receptors. The receptor is of central importance for infec- receptors that act as decoy molecules to neutralize cy- tion and typically serves to enrich virus particles on target tokines [28]. In addition, herpes- and poxviruses encode cells. Viruses have selected their primary receptors on the seven transmembrane G-protein-coupled receptors basis of availability and accessibility, functional coupling (GPCRs), presumably derived from the host chemokine to coreceptors and perhaps also downregulation to prevent system (for recent reviews, see [29, 30]). Although most superinfection and support viral release (reviewed in [40]). of these receptors are still orphan receptors, the human Members from one virus family can choose a large variety herpesvirus 8 protein ORF74 seems to be positively of receptors, as exemplified in a recent survey of retroviral modulated by angiogenic chemokines and is associated receptors (reviewed in [41]). Broad availability is a promi- with cell transformation through phospholipase C and nent feature of large glycosamino-glycans, present in he- mitogen-activated protein kinase (MAPK) signalling paran sulphate and chondroitin sulphate proteoglycans. pathways. It is likely that ORF74 has a major role in Glycosamino-glycans have been reported to serve as pri- HHV-8-associated Kaposi’s sarcomas. This example un- mary attachment sites for HSV-1 [42, 43], CMV [44], derscores the principle that viruses take control of cell adeno-associated virus-2 (AAV-2) [45] and for the sub- proliferation by pirating and
Recommended publications
  • Enhanced Expression of Vascular Endothelial Growth Factor (VEGF) Plays a Critical Role in the Tumor Progression Potential Induced by Simian Virus 40 Large T Antigen
    Oncogene (2002) 21, 2896 ± 2900 ã 2002 Nature Publishing Group All rights reserved 0950 ± 9232/02 $25.00 www.nature.com/onc Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen Alfonso Catalano1, Mario Romano*,2, Stefano Martinotti3 and Antonio Procopio*,1 1Institute of Experimental Pathology, University of Ancona, Faculty of Medicine, Via Ranieri, 60131 Ancona, Italy; 2Department of Human Pathology, University of Messina, 98125 Messina, Italy; 3Department of Oncology and Neuroscience, `G. D'Annunzio' University, Chieti, Italy Vascular endothelial growth factor (VEGF), an impor- disorders, including mesotheliomas (Kumar-Singh et tant angiogenic factor, regulates cell proliferation, al., 1999). Among these, VEGF, whose crucial role in dierentiation, and apoptosis through activation of its tumor angiogenesis is well established (Hanahan and tyrosine-kinase receptors, such as Flt-1 and Flk-1/Kdr. Folkman., 1996), acts also as a potent mitogen and Human malignant mesothelioma cells (HMC), which survival factor for human malignant mesothelioma have wild-type p53, express VEGF and exhibit cell cells (HMC). In fact, VEGF regulates HMC prolifera- growth increased by VEGF. Here, we demonstrate that tion through its tyrosine-kinase receptors activation early transforming proteins of simian virus (SV) 40, large (i.e. Flt-1 and KDR/¯k-1) (Strizzi et al., 2001). In tumor antigen (Tag) and small tumor antigen (tag), addition, VEGF is the main eector of 5-lipoxygenase which have been associated with mesotheliomas, en- action on HMC survival (Romano et al., 2001). Thus, hanced HMC proliferation by inducing VEGF expres- VEGF plays a key role by regulating multiple sion.
    [Show full text]
  • A Polyoma Mutant That Encodessmall T Antigen but Not Middle T Antigen
    MOLECULAR AND CELLULAR BIOLOGY, Dec. 1984, p. 2774-2783 Vol. 4, No. 12 0270-7306/84/122774-10$02.00/0 Copyright © 1984, American Society for Microbiology A Polyoma Mutant That Encodes Small T Antigen But Not Middle T Antigen Demonstrates Uncoupling of Cell Surface and Cytoskeletal Changes Associated with Cell Transformation T. JAKE LIANG, GORDON G. CARMICHAEL,t AND THOMAS L. BENJAMIN* Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115 Received 2 July 1984/Accepted 31 August 1984 The hr-t gene of polyoma virus encodes both the small and middle T (tumor) antigens and exerts pleiotropic effects on cells. By mutating the 3' splice site for middle T mRNA, we have constructed a virus mutant, Py8O8A, which fails to express middle T but encodes normal small and large T proteins. The mutant failed to induce morphological transformation or growth in soft agar, but did stimulate postconfluent growth of normal cells. Cells infected by Py8O8A became fully agglutinable by lectins while retaining normal actin cable architecture and normal levels of extracellular fibronectin. These properties of Py8O8A demonstrated the separability of structural changes at the cell surface from those in the cytoskeleton and extracellular matrix, parameters which have heretofore been linked in the action of the hr-t and other viral oncogenes. The early region of polyoma encodes three proteins de- substitution of phenylalanine for tyrosine at position 315 in tected as tumor (T) antigens. These polypeptides of 100,000 middle T has been made and studied in two laboratories, daltons (100K; large T), 56K (middle T), and 22K (small T) with different results.
    [Show full text]
  • Link of a Ubiquitous Human Coronavirus to Dromedary Camels
    Link of a ubiquitous human coronavirus to dromedary camels Victor M. Cormana,b,1, Isabella Eckerlea,1, Ziad A. Memishc, Anne M. Liljanderd, Ronald Dijkmane,f, Hulda Jonsdottire,f, Kisi J. Z. Juma Ngeiywag, Esther Kamaug, Mario Younanh, Malakita Al Masrii, Abdullah Assirii, Ilona Gluecksj, Bakri E. Musak, Benjamin Meyera, Marcel A. Müllera, Mosaad Hilalil, Set Bornsteinm, Ulrich Werneryn, Volker Thiele,f, Joerg Joresd,o, Jan Felix Drexlera,b,2, and Christian Drostena,b,2 aUniversity of Bonn Medical Centre, 53127 Bonn, Germany; bGerman Centre for Infection Research, partner site Bonn–Cologne, Germany; cCollege of Medicine, Alfaisal University, 11533 Riyadh, Kingdom of Saudi Arabia; dInternational Livestock Research Institute, Nairobi, Kenya; eDepartment of Infectious Diseases and Pathobiology, Vetsuisse Faculty Bern, University of Bern, 3012 Bern, Switzerland; fFederal Department of Home Affairs, Institute of Virology and Immunology, Bern and Mittelhausern, Switzerland; gMinistry of Agriculture, Livestock, and Fisheries, State Department of Livestock, Department of Veterinary Services, Nairobi, Kenya; hVétérinaires Sans Frontières Germany, Nairobi, Kenya; iMinistry of Health, 11176 Riyadh, Kingdom of Saudi Arabia; jVétérinaires Sans Frontières Suisse, Nairobi, Kenya; kMinistry of Science and Communication, Khartoum, Sudan; lCairo University, 12613 Giza, Egypt; mNational Veterinary Institute, 75189 Uppsala, Sweden; nCentral Veterinary Research Laboratory, Dubai, United Arab Emirates; and oInstitute of Veterinary Bacteriology, University of Bern, 3001 Bern, Switzerland Edited by Luis Enjuanes, Centro Nacional de Biotecnología-Consejo Superior de Investigaciones Cientificas, Madrid, Spain, and accepted by Editorial Board Member Diane E. Griffin June 27, 2016 (received for review March 17, 2016) The four human coronaviruses (HCoVs) are globally endemic respiratory ecological history of these ubiquitous human pathogens.
    [Show full text]
  • How Influenza Virus Uses Host Cell Pathways During Uncoating
    cells Review How Influenza Virus Uses Host Cell Pathways during Uncoating Etori Aguiar Moreira 1 , Yohei Yamauchi 2 and Patrick Matthias 1,3,* 1 Friedrich Miescher Institute for Biomedical Research, 4058 Basel, Switzerland; [email protected] 2 Faculty of Life Sciences, School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1TD, UK; [email protected] 3 Faculty of Sciences, University of Basel, 4031 Basel, Switzerland * Correspondence: [email protected] Abstract: Influenza is a zoonotic respiratory disease of major public health interest due to its pan- demic potential, and a threat to animals and the human population. The influenza A virus genome consists of eight single-stranded RNA segments sequestered within a protein capsid and a lipid bilayer envelope. During host cell entry, cellular cues contribute to viral conformational changes that promote critical events such as fusion with late endosomes, capsid uncoating and viral genome release into the cytosol. In this focused review, we concisely describe the virus infection cycle and highlight the recent findings of host cell pathways and cytosolic proteins that assist influenza uncoating during host cell entry. Keywords: influenza; capsid uncoating; HDAC6; ubiquitin; EPS8; TNPO1; pandemic; M1; virus– host interaction Citation: Moreira, E.A.; Yamauchi, Y.; Matthias, P. How Influenza Virus Uses Host Cell Pathways during 1. Introduction Uncoating. Cells 2021, 10, 1722. Viruses are microscopic parasites that, unable to self-replicate, subvert a host cell https://doi.org/10.3390/ for their replication and propagation. Despite their apparent simplicity, they can cause cells10071722 severe diseases and even pose pandemic threats [1–3].
    [Show full text]
  • Review Article Human Polyomaviruses in Skin Diseases
    SAGE-Hindawi Access to Research Pathology Research International Volume 2011, Article ID 123491, 12 pages doi:10.4061/2011/123491 Review Article Human Polyomaviruses in Skin Diseases Ugo Moens,1 Maria Ludvigsen,1 and Marijke Van Ghelue2 1 Institute of Medical Biology, Faculty of Health Sciences, University of Tromsø, 9037 Tromsø, Norway 2 Department of Medical Genetics, University Hospital of Northern-Norway, 9038 Tromsø, Norway Correspondence should be addressed to Ugo Moens, [email protected] Received 28 February 2011; Accepted 29 June 2011 Academic Editor: Gerardo Ferrara Copyright © 2011 Ugo Moens et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Polyomaviruses are a family of small, nonenveloped viruses with a circular double-stranded DNA genome of ∼5,000 base pairs protected by an icosahedral protein structure. So far, members of this family have been identified in birds and mammals. Until 2006, BK virus (BKV), JC virus (JCV), and simian virus 40 (SV40) were the only polyomaviruses known to circulate in the human population. Their occurrence in individuals was mainly confirmed by PCR and the presence of virus-specific antibodies. Using the same methods, lymphotropic polyomavirus, originally isolated in monkeys, was recently shown to be present in healthy individuals although with much lower incidence than BKV, JCV, and SV40. The use of advanced high-throughput sequencing and improved rolling circle amplification techniques have identified the novel human polyomaviruses KI, WU, Merkel cell polyomavirus, HPyV6, HPyV7, trichodysplasia spinulosa-associated polyomavirus, and HPyV9.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2004/0023207 A1 Polansky (43) Pub
    US 20040023207A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2004/0023207 A1 Polansky (43) Pub. Date: Feb. 5, 2004 (54) ASSAYS FOR DRUG DISCOVERY BASED ON Publication Classification MICROCOMPETITION WITH A FOREIGN POLYNUCLEOTIDE (51) Int. Cl." .............................. C12O 1/70; C12O 1/68; C12N 15/85; C12N 15/86 (52) U.S. Cl. .................. 435/5; 435/6; 435/455; 435/456 (76) Inventor: Hanan Polansky, Rochester, NY (US) (57) ABSTRACT Correspondence Address: A recent discovery showed that microcompetition between a Hanan Polansky foreign polynucleotide and a cellular polynucleotide is a risk 3159 S. Winton Rd. factor for Some of the major chronic diseases. The invention Rochester, NY 14623 (US) uses this novel discovery to present assays for Screening compounds based on their effectiveness in modulating Such microcompetition. The effective compounds can be used in (21) Appl. No.: 10/211,295 treatment of these chronic diseases. The invention also presents assays for Screening compounds that can be used in treatment of chronic diseaseS resulting from other foreign (22) Filed: Aug. 1, 2002 polynucleotide-type disruptions. Patent Application Publication Feb. 5, 2004 Sheet 1 of 6 US 2004/0023207 A1 s e 2 9 s H c 2 4 competitor plasmid/test plasmid Figure 1 1 O 09% 1 2 3 4 competitor plasmid/test plasmid -H Ltk- (pSV2Neo) -A-ML (pSV2neo) . A- - - Ltk- (pA1 Oneo) - - - - - - Mill (pA1 Oneo) Figure 2 Patent Application Publication Feb. 5, 2004 Sheet 2 of 6 US 2004/0023207 A1 e 2 r U H c O s S 2 3. Molar ratio (pSV2NeolhMT-ilA-CAT) Figure 3 Patent Application Publication Feb.
    [Show full text]
  • Tumor Antigen (Hybrid Trp-Lac Promoter/Actin Cable Effect) ILAN BIKEL*, THOMAS M
    Proc. NatL Acad. Sci. USA Vol. 80, pp. 906-910, February 1983 Biochemistry Purification of biologically active simian virus 40 small tumor antigen (hybrid trp-lac promoter/actin cable effect) ILAN BIKEL*, THOMAS M. ROBERTS*, MARILUCI T. BLADON*, ROBERT GREEN*, EGON AMANNt, AND DAVID M. LIVINGSTON* *The Sidney Farber Cancer Institute and The Departments of Medicine and Pathology, Harvard Medical School, Boston, Massachusetts 02115; and tDepartment of Biochemistry and Molecular Biology, Harvard University, Cambridge, Massachusetts 02138 Communicated by Morris Friedkin, October 29, 1982 The simian virus 40 small tumor antigen (t antigen) gene has been were grown in L broth containing ampicillin (40 Ag/ml) to an cloned downstream from a hybrid Escherichia coli trp-lac pro- ODW of0.7 and then incubated for 2 hr with 5 mM isopropyl moter anda suitable ribosome binding site. Abacterial clone (865i) f3-D-thiogalactopyranoside. Radiolabeling of proteins with transformed by such a plasmid (pTR865) expresses this gene and, [3S]methionine was performed as described (31). under optimal conditions, can produce .5% ofits total protein as t Antigen and Protein Assays. t antigen was detected by Na- t antigen. Soluble extracts ofsuch a clone were relatively depleted DodSO4/polyacrylamide slab gel electrophoresis (32) using 4% in t antigen, which was found in the initial pellet fraction. The stacking and 15% separating gels. Marker proteins were bovine protein was recovered from this fraction in a significantly purified serum albumin (Mr 68,000), carbonic anhydrase (29,000), form byextraction with urea-containing buffer. After gel filtration concentrations were deter- of such t antigen-enriched solutions, highly purified protein was and myoglobin (17,000).
    [Show full text]
  • PP2A-Dependent Disruption of Centrosome Replication and Cytoskeleton Organization in Drosophila by SV40 Small Tumor Antigen
    Oncogene (2008) 27, 6334–6346 & 2008 Macmillan Publishers Limited All rights reserved 0950-9232/08 $32.00 www.nature.com/onc ORIGINAL ARTICLE PP2A-dependent disruption of centrosome replication and cytoskeleton organization in Drosophila by SV40 small tumor antigen S Kotadia1,LRKao1, SA Comerford2, RT Jones1, RE Hammer3 and TL Megraw1 1Department of Pharmacology, The Cecil and Ida Green Center for Reproductive Biology Sciences, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA; 2Department of Molecular Genetics, The Cecil and Ida Green Center for Reproductive Biology Sciences, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA and 3Department of Biochemistry, The Cecil and Ida Green Center for Reproductive Biology Sciences, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA Viruses of the DNA tumor virus family share the ability to cell-cycle and apoptosis regulation, viral oncoproteins transform vertebrate cells through the action of virus- transform cells. Investigation of DNA tumor virus encoded tumor antigens that interfere with normal cell oncoproteins has led to the identification of many physiology. They accomplish this very efficiently by fundamental mechanisms of tumor suppression (Lavia inhibiting endogenous tumor suppressor proteins that et al., 2003; Ahuja et al., 2005). By altering the activity control cell proliferation and apoptosis. Simian virus 40 of p53, retinoblastoma protein and serine/threonine (SV40) encodes two oncoproteins, large tumor antigen, protein phosphatase 2A (PP2A), three key tumor which directly inhibits the tumor suppressors p53 and Rb, suppressors, SV40 can cause tumor formation in and small tumor antigen (ST), which interferes with transgenic mouse models (Ahuja et al., 2005; Arroyo serine/threonine protein phosphatase 2A (PP2A).
    [Show full text]
  • The Multi-Functional Reovirus Σ3 Protein Is a Virulence Factor That Suppresses Stress Granule Formation to Allow Viral Replicat
    bioRxiv preprint doi: https://doi.org/10.1101/2021.03.22.436456; this version posted March 22, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 The multi-functional reovirus σ3 protein is a 2 virulence factor that suppresses stress granule 3 formation to allow viral replication and myocardial 4 injury 5 6 Yingying Guo1, Meleana Hinchman1, Mercedes Lewandrowski1, Shaun Cross1,2, Danica 7 M. Sutherland3,4, Olivia L. Welsh3, Terence S. Dermody3,4,5, and John S. L. Parker1* 8 9 1Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, 10 Ithaca, New York 14853; 2Cornell Institute of Host-Microbe Interactions and Disease, 11 Cornell University, Ithaca, New York 14853; Departments of 3Pediatrics and 12 4Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, 13 Pittsburgh, PA 15224; and 5Institute of Infection, Inflammation, and Immunity, UPMC 14 Children’s Hospital of Pittsburgh, PA 15224 15 16 17 Running head: REOVIRUS SIGMA3 PROTEIN SUPPRESSES STRESS GRANULES 18 DURING INFECTION 19 20 * Corresponding author. Mailing address: Baker Institute for Animal Health, College 21 of Veterinary Medicine, Cornell University, Hungerford Hill Road; Ithaca, NY 14853. 22 Phone: (607) 256-5626. Fax: (607) 256-5608. E-mail: [email protected] 23 Word count for abstract: 261 24 Word count for text: 12282 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.03.22.436456; this version posted March 22, 2021.
    [Show full text]
  • Interactions Between Polyomavirus Large T Antigen and the Viral Replication Origin Dna: How and Why
    INTERACTIONS BETWEEN POLYOMAVIRUS LARGE T ANTIGEN AND THE VIRAL REPLICATION ORIGIN DNA: HOW AND WHY by Yu-Cai Peng Department of Microbiology and Immunology McGill University, Montreal April, 1999 A thesis submitted to the Faculty of Craduate Studies and Re3earch in partial fulfullmeat of the requirements of the degree of doctor of philosophy @Yu-Cai Peng, 1999 National Library Biblioth ue nationale 1+1 of Canada du Cana7 a Acquisitions and Acquisitions et Bibliographie Srvices services bibliographiques 395 Wellmgton Street 395, nie Weliingîm Ottawa ON KIA ON4 OrtawaON K1AON4 Canada Canada The author has granted a non- L'auteur a accordé une licence non exclusive Licence ailowing the exclusive permettant à la National Library of Canada to Bibliothèque nationale du Canada de reproduce, loan, distribute or sell reproduire, prêter, distribuer ou copies of this thesis in microform, vendre des copies de cette thèse sous paper or electronic formats. la forme de microfichelfilm, de reproduction sur papier ou sur format électronique. The author retains ownership of the L'auteur conserve la propriété du copyright in this thesis. Neither the droit d'auteur qui protège cette thèse. thesis nor substantial extracts fkom it Ni la thèse ni des extraits substantiels may be printed or othenvise de celle-ci ne doivent être imprimés reproduced without the author's ou autrement reproduits sans son permission. autorisation. TABLE OF CONTENTS Page Tableofcontents................................................... I Abstract .......................................................... VI Resumé........................................................... VI11 Acknowledgements ................................................. X Claim of contribution to kaowledge ................................... XI Listoffigures ...................................................... XllI Guidelines regarding doctoral thesis ................................... XV CHAPTER 1. INTRODUCTION .................................... 1 1. Overview: Life cycle of polyomavirus and simian virus 40 ..........
    [Show full text]
  • Polyoma Virus Small Tumor Antigen Pre-Mrna Splicing Requires Cooperation Between Two 3' Splice Sites Hui GE, JONATHAN NOBLE, JOHN COLGAN, and JAMES L
    Proc. Nati. Acad. Sci. USA Vol. 87, pp. 3338-3342, May 1990 Biochemistry Polyoma virus small tumor antigen pre-mRNA splicing requires cooperation between two 3' splice sites Hui GE, JONATHAN NOBLE, JOHN COLGAN, AND JAMES L. MANLEY Department of Biological Sciences, Columbia University, New York, NY 10027 Communicated by Joan A. Steitz, January 25, 1990 (receivedfor review December 13, 1989) ABSTRACT We have studied splicing ofthe polyoma virus proteins also likely play a role in the splicing reaction (e.g., early region pre-mRNA in vitro. This RNA is alternatively refs. 19-22). spliced in vivo to produce mRNA encoding the large, middle- The complexity and size of the splicing apparatus suggests sized (MTAg), and small (StAg) tumor antigens. Our primary that steric constraints may play a role in splicing of some interest was to learn how the 48-nucleotide StAg intron is pre-mRNAs. Consistent with this proposal, several studies excised, because the length of this intron is significantly less have shown that introns in higher eukaryotes have a mini- than the apparent minimum established for mammalian in- mum size requirement. Roughly 45 nucleotides (nt) must trons. Although the products ofall three splices are detected in separate the 5' splice site and branch point (23-27), and the vitro, characterization of the pathway and sequence require- minimum distance between the branch point and 3' splice site ments of StAg splicing suggests that splicing factors interact appears to be approximately 18 nt (26, 28). The simian virus with the precursor RNA in an unexpected way to catalyze 40 small tumor antigen pre-mRNA contains an intron of66 nt removal ofthis intron.
    [Show full text]
  • Genomics and Structure/Function Studies of Rhabdoviridae Proteins Involved in Replication and Transcription
    Genomics and structure/function studies of Rhabdoviridae proteins involved in replication and transcription. R. Assenberg, O Delmas, B Morin, C Graham, X de Lamballerie, C Laubert, B Coutard, J Grimes, J Neyts, R J Owens, et al. To cite this version: R. Assenberg, O Delmas, B Morin, C Graham, X de Lamballerie, et al.. Genomics and struc- ture/function studies of Rhabdoviridae proteins involved in replication and transcription.. Antivi- ral Research, Elsevier Masson, 2010, 87 (2), pp.149-61. 10.1016/j.antiviral.2010.02.322. pasteur- 01492926 HAL Id: pasteur-01492926 https://hal-pasteur.archives-ouvertes.fr/pasteur-01492926 Submitted on 21 Apr 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution - NonCommercial - ShareAlike| 4.0 International License *Manuscript Genomics and structure/function studies of Rhabdoviridae proteins involved in replication and transcription R. Assenberg1, O. Delmas2, B. Morin3, S. C. Graham1, X. De Lamballerie4, C. Laubert5, B. Coutard3, J. M. Grimes1, J. Neyts6, R. J. Owens1,
    [Show full text]